The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO 2022 | Perioperative treatment approaches for gastroesophageal cancers

Name: Perioperative treatment approaches for gastroesophageal cancers
Uploaded: 2022-06-06T00:00:00Z
Duration: 2 min 13 s
Description: Nataliya Uboha, MD, PhD, University of Wisconsin, Madison, WI, discusses perioperative treatment approaches for esophageal cancer, gastroesophageal junction cancer, and gastric cancer, including current standards of care and future therapeutic possibilities. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Nataliya Uboha • 6 Jun 2022

ASCO 2022

Esophageal Cancer Gastric Cancer Gastroesophageal Cancer Gastrointestinal Cancer Antibodies Avelumab Ipilimumab Nivolumab

Nataliya Uboha, MD, PhD, University of Wisconsin, Madison, WI, discusses perioperative treatment approaches for esophageal cancer, gastroesophageal junction cancer, and gastric cancer, including current standards of care and future therapeutic possibilities. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.